TABLE 3.
Population studies examining the effect of resistant starch on the intestinal microbiota
| Type | Duration and dose | Population | Microbial groups showing alterations |
|---|---|---|---|
| RS2 [128] | 3 wk, 33 g/d | 13 healthy human subjects | Bacteroidetes, Actinobacteria, Parabacteroides distasonis, Bifidobacterium adolescentis↑ Firmicutes, Ruminococcaceae, Faecalibacterium↓ |
| RS4 [128] | Ruminococcus bromii, Eubacterium rectale↑ | ||
| RS3 [129] | 3 wk, 25.56 g/d | 14 overweight men | Ruminococcus bromii, Eubacterium rectale↑ |
| RS3 [130] | 3 wk, 20 g/d | 14 obese men | Ruminococcaceae↑, Papillibacter cinnamivorans↓ |
| RS2 [131] | 4 wk, 8.5 g/d | 18 children | Actinobacteria, Lactobacillus↑ Firmicutes, Roseburia, Blautia, Lachnospiraceae incertae sedis ↓ |
| RS2 [132] | 3 wk, 24 g/d | 20 young adults | Bifidobacterium adolescentis, Ruminococcus bromii, Eubacterium rectale↑ |
| RS2 [133] | 12 wk, 21 g/d | 84 older and middle-aged adults | Bifidobacterium↑ |
| RS2 [134] | 4 wk, 40 g/d | 19 normal weight subjects | Ruminococcaceae_UCG-005↑ |
| RS2 [135] | 4 wk, 20 g/d; 4 wk, 25 g/d |
9 ESRD subjects | Faecalibacterium↑ |
| RS2 [136] | 2 wk, 20–34 g/d | 174 healthy young adults | Ruminococcus bromii, Clostridium chartatabidum, Eubacterium rectale↑ |
| RS2 [137] | 4 wk, 16 g/d | 10 HD subjects | Roseburia, Ruminococcus gauvreauii↑ |
| RS2 [138] | 1 wk, 14–19 g/d | 30 healthy adults | Ruminococcus, Gemmiger↑ |
Abbreviations: ↑: Increased; ↓: Decreased; ESRD, end-stage renal disease; HD, hemodialysis; RS, resistant starch.